These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2473272)

  • 1. [Diagnostic meningococcal sera and their quality].
    Andreeva ZM; Kovaleva VV; Filimonova IN
    Lab Delo; 1989; (5):74-6. PubMed ID: 2473272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative evaluation of the methods of monitoring the activity of diagnostic meningococcal group-specific sera].
    Ereshchenko VV; Petrova ZS; Zhukova LF
    Lab Delo; 1982; (9):567-9. PubMed ID: 6183530
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of industrially produced diagnostic meningococcal agglutinating sera].
    Trushnikova AG
    Lab Delo; 1985; (5):302-4. PubMed ID: 2409341
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of N. meningitidis group B antigens by MB-Dot-ELISA in patients with meningitis.
    Alkmin M das G; Landgraf IM; Shimizu SH
    Bull Pan Am Health Organ; 1996 Sep; 30(3):212-7. PubMed ID: 8897721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of bacterial meningitis by counterimmunoelectrophoresis.
    Edwards EA; Muehl PM; Peckinpaugh RO
    J Lab Clin Med; 1972 Sep; 80(3):449-54. PubMed ID: 4403430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
    Chen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Method of obtaining meningococcal agglutinating serum of high titre and its use in the indirect immunofluorescence test].
    Okropiridze GG; Pavlov GA; Mal'tseva AN; Akopiants EIa; Balashova RR
    Lab Delo; 1977; (8):489-91. PubMed ID: 72859
    [No Abstract]   [Full Text] [Related]  

  • 8. Active surveillance of meningococcal meningitis in Poland.
    Tyski S; Grzybowska W; Lind I
    Cent Eur J Public Health; 1998 Aug; 6(3):219-24. PubMed ID: 9787924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing host susceptibility to meningococcal disease.
    Winstanley FP; Blackwell CC; Weir DM
    Biomed Pharmacother; 1985; 39(4):167-70. PubMed ID: 3933588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapid detection of meningococcal antigens in cerebrospinal fluid by staphylococcal protein A coagglutination].
    Chen HC
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Apr; 6(2):122-4. PubMed ID: 3926321
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningitis antigen detection: interpretation of agglutination by ultrasound-enhanced latex immunoassay.
    Sobanski MA; Gray SJ; Cafferkey M; Ellis RW; Barnes RA; Coakley WT
    Br J Biomed Sci; 1999; 56(4):239-46. PubMed ID: 10795366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meningococcal meningitis with antigens common to Neisseria meningitidis and Neisseria gonorrhoeae].
    Sanchis-Bayarri Vaillant V; Donderis Torrens S; Martínez Medina MC; Sanchis-Bayarri Bernal MR
    Rev Clin Esp; 1986 Apr; 178(6):315-6. PubMed ID: 3088683
    [No Abstract]   [Full Text] [Related]  

  • 13. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual report of the Australian Meningococcal Surveillance Programme 1996.
    Commun Dis Intell; 1997 Aug; 21(16):217-21. PubMed ID: 9270181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of rapid diagnostic tests for meningococcal meningitis in Niger.
    Boisier P; Mahamane AE; Hamidou AA; Sidikou F; Djibo S; Nato F; Chanteau S
    Trop Med Int Health; 2009 Jan; 14(1):111-7. PubMed ID: 19017310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The activity of meningococcal agglutinating sera in coagglutination and precipitation reactions].
    Kaziakhmedova DB; Goncharov BS; Trushnikova AG
    Lab Delo; 1991; (2):63-5. PubMed ID: 1709996
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in obtaining group meningococcal antiserums (Sanitary-epidemiological station, Leninsk, Kzyl-Orlinsk district)].
    Polianin VA
    Lab Delo; 1975; (4):251-2. PubMed ID: 57303
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specific antibody response in carriers of N. meningitidis].
    Tomásik E; Kuzemenská P
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):221-7. PubMed ID: 2507173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of meningococcal disease using PCR].
    Prats G; Margall N; Majó M
    Rev Esp Salud Publica; 1998; 72(5):435-6. PubMed ID: 9951338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.